VECTURA
DEAD

Serial Number

76122117

Owner

Vectura Limited

Attorney

Robert C. Klinger

Filing Date

Sep 5, 2000

Add to watchlist:

No watchlists yet
View on USPTO

VECTURA Trademark

Serial Number: 76122117 • Registration: 2645169

VECTURA is a trademark filed by Vectura Limited on September 5, 2000. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Vectura Limited (17 trademarks)

1 Prospect West
Chippenham, Wiltshire SN146FH , GB

Entity Type: 99

Vectura Group plc (2 trademarks)

1 Prospect West
Chippenham, Wiltshire SN14 6FH , GB

Entity Type: 99

Trademark Details

Filing Date

September 5, 2000

Registration Date

November 5, 2002

Published for Opposition

August 13, 2002

Cancellation Date

June 13, 2009

Goods & Services

Pharmaceutical and veterinary preparations for the treatment of diseases or conditions of the respiratory system; inhalable pharmaceutical and inhalable veterinary preparations for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; inhalable pharmaceutical and inhalable veterinary preparations for the alleviation or prevention of pain or inflammation; inhalers filled with powders for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; powders for asthma inhalers; powders for transdermal injection for the alleviation or prevention of pain, for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and veterinary preparations for oral ingestion for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and veterinary preparations for topical administration for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastor-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions

Chemicals, namely, chemical substances and products for use in the manufacture of pharmaceutical preparations

Medical and veterinary instruments and apparatus parts and fittings therefor, namely, inhaler devices sold empty for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions, and parts and fittings therefor; dispensing devices for the metering and/or dispensing of orally ingestible drugs for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous systems, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; aerosol dispensers for medical use, for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions

Medical and scientific research, namely, development, design, testing and investigation of pharmaceutical preparations, drug delivery devices and drug formulation

Filing History

CANCELLED SEC. 8 (6-YR)
Jun 13, 2009 C8..
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jul 30, 2008 ASGN
CASE FILE IN TICRS
Jan 24, 2008 CFIT
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Oct 10, 2007 ASCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 14, 2007 ASGN
REGISTERED-PRINCIPAL REGISTER
Nov 5, 2002 R.PR
PAPER RECEIVED
Sep 23, 2002 MAIL
PUBLISHED FOR OPPOSITION
Aug 13, 2002 PUBO
PUBLISHED FOR OPPOSITION
Aug 13, 2002 PUBO
NOTICE OF PUBLICATION
Jul 24, 2002 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
May 14, 2002 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 19, 2002 CRFA
LETTER OF SUSPENSION MAILED
Nov 19, 2001 CNSL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 18, 2001 CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 18, 2001 CRFA
NON-FINAL ACTION MAILED
Jan 29, 2001 CNRT
ASSIGNED TO EXAMINER
Jan 23, 2001 DOCK